Skip to main content
Equibles

Zurcher Kantonalbank (Zurich Cantonalbank)

Bank

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 1368163 ZURICH, V8
Back to BTAI Full portfolio

Position in BTAI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2
+$0 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 47 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Zurcher Kantonalbank (Zurich Cantonalbank) holds $123,850,439 across 36 Drug Manufacturers - Specialty & Generic names. BTAI ranks #35 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 51,700 $28,012,611
2 NBIX
Neurocrine Biosciences Inc
 140,854 $23,739,533
3 TEVA
Teva Pharmaceutical Industries Ltd
 694,126 $23,516,988
4 VTRS
Viatris Inc
 668,826 $10,620,956
5 ZTS
Zoetis Inc.
 125,452 $9,014,980
6 ELAN
Elanco Animal Health Inc
 225,330 $5,545,371
7 LNTH
Lantheus Holdings, Inc.
 30,555 $3,389,771
8 ALKS
Alkermes plc.
 61,584 $3,227,001

All Filings in BTAI

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2 2
2026-03-31 $2 2
2025-12-31 $3 2
2025-09-30 $263 103
2025-06-30 $186 103
2025-03-31 $209 103
2024-12-31 $618 1,653
2024-09-30 $3,677 6,028
2024-06-30 $8,419 6,578
2024-03-31 $21,550 7,642
2023-12-31 $23,287 7,894
2023-09-30 $28,872 11,412
2023-06-30 $81,684 12,265
2023-03-31 $225,841 12,103
2022-12-31 $240,189 11,182
2022-09-30 $88,129 7,456
2022-06-30 $103,633 7,851
2022-03-31 $171,545 8,204
2021-12-31 $171,483 8,435
2021-09-30 $254,333 8,380
2021-06-30 $153,436 5,280
2021-03-31 $219,382 5,083
2020-12-31 $84,823 1,836
2020-09-30 $79,608 1,836